期刊文献+

补肾益气类方药延缓骨骼肌线粒体功能退化的研究概况 被引量:5

Review of Research on Bushen Yiqi Prescription in Retarding Mitochondrial Function Degradation of Skeletal Muscle
原文传递
导出
摘要 采用文献综述法,分析线粒体结构、膜通透性、氧化损伤、呼吸功能、酶活性及线粒体生物合成与骨骼肌衰老的关系,探讨补肾益气类方药对衰老骨骼肌线粒体结构和功能的影响,为采取合适中药延缓骨骼肌衰老提供理论依据。研究发现随着机体逐渐衰老,骨骼肌线粒体呈现出结构退化、膜通透性改变、氧化损伤、呼吸功能、酶活性及线粒体生物合成能力下降等改变,补肾益气类方药可通过改善衰老骨骼肌线粒体的结构和功能,延缓骨骼肌的衰老,但其深层作用机制及作用途径尚不明晰。在中医药理论体系指导下,结合现代实验技术,多角度、多层次地探明补肾益气类方药在延缓骨骼肌衰退中的作用机制及构效关系,是开发此类方药过程中亟待解决的问题。 This article uses literature summary method to analyze relationship between mitochondrial structure, membrane permeability, oxidative damage, respiratory function, enzyme activity, mitochondria biosynthesis and skeletal muscle aging,it explores influence of Bushen Yiqi prescription on mitochondria structure and function of ageing skeletal muscle,in order to provide theory basis for taking appropriate traditional Chinese medicine to retard skeletal muscle ageing. It is found that,as body gradually aging,mitochondrial structure in skeletal muscle became disorder,permeability of mitochondrial membrane changed,mitochondria suffers oxidative damaged, respiratory function, enzyme activity and mitochondria biosynthesis decreased, Bushen Yiqi prescription can retard skeletal muscle aging through improving mitochondrial structure and function of aging skeletal muscle, but its deep mechanism of action was not clear. How to combine modern experimental technology,under guidance of theory system of traditional Chinese medicine, multi-angle and multi-level to ascertain mechanism and structure-activity relationship of Bushen Yiqi prescription in retarding skeletal muscle aging is the key issue to be solved in process of developing this kind of herbs and formulae.
机构地区 上海中医药大学
出处 《中国实验方剂学杂志》 CAS CSCD 北大核心 2016年第1期224-228,共5页 Chinese Journal of Experimental Traditional Medical Formulae
基金 国家自然科学基金项目(81473583) 上海市教委"085"一流学科建设科技创新支撑计划项目(085ZY1204) 上海市教委科研项目(2012JW29)
关键词 补肾益气 中药 衰老 骨骼肌 线粒体 Bushen Yiqi traditional Chinese medicine aging skeletal muscle mitochondria
  • 相关文献

参考文献35

  • 1王顺利,史仍飞.衰老骨骼肌蛋白质的合成与抵抗[J].中国组织工程研究,2013,17(15):2835-2842. 被引量:9
  • 2Wagatsuma A,Sakuma K.Molecular mechanisms for age-associated mitochondrial deficiency in skeletal muscle[J].J Aging Res,2012,doi:10.1155/2012/768304.
  • 3Peterson C M,Johannsen D L,Ravussin E.Skeletal muscle mitochondria and aging:A review[J].J Aging Res,2012,doi:10.1155/2012/194821.
  • 4Kaufman B A,Durisic N,Mativetsky J M,et al.The mitochondrial transcription factor TFAM coordinates the assembly of multiple DNA molecules into nucleoid-like structures[J].Mol Biol Cell,2007,18(9):3225-3236.
  • 5Rukhsar Ahmad,蒋鹏程,顾韵,刘嫣方,陈芹,步雪峰,谢黎,林志强,钱炜.不同年龄人群肌肉组织中7种线粒体酶的表达差异[J].江苏大学学报(医学版),2014,24(1):22-25. 被引量:2
  • 6Di Mauro S,Tanji K,Bonilla E,et al.Mitochondrial abnormalities in muscle and other aging cells:classification,causes,and effects[J].Muscle Nerve,2002,26(5):597-607.
  • 7Fossati S,Cam J,Meyerson J,et al.Differential activation of mitochondrial apoptotic pathways by vasculotropic amyloid-beta variants in cells composing the cerebral vessel walls[J].FASEB J,2010,24(1):229-241.
  • 8Mac Farlane M,Williams A C.Apoptosis and disease:a life or death decision[J].EMBO Rep,2004,5(7):674-678.
  • 9Marzetti E,Hwang J C Y,Lees H A,et al.Mitochondrial death effectors:relevance to sarcopenia and disuse muscle atrophy[J].Biochim Biophys Acta,2010,1800(3):235-244.
  • 10Antonsson B.Bax and other pro-apoptotic Bcl-2 family“killer-proteins”and their victim the mitochondrion[J].Cell Tissue Res,2001,306(3):347-361.

二级参考文献214

共引文献198

同被引文献50

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部